MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

Inicio・Lista de Acciones・Dynavax Technologies Corp

Dynavax Technologies Corp

Cerrado

SectorSanidad

9.93 0.91

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

9.79

Máximo

9.97

Métricas clave
By Trading Economics
Ingresos	115M 19M
Ventas	27M 95M
P/B Media del Sector	58.75 36.442
Margen de beneficios	19.615
Empleados	405
EBITDA	119M 25M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+130.62% upside

Dividendos
By Dow Jones
Próximas Ganancias	6 nov 2025

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-164M 1.2B
Apertura anterior	9.02
Cierre anterior	9.93

Noticias sobre sentimiento de mercado

By Acuity

31%

69%

94 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

9.62 / 10.9 Soporte y Resistencia

Dynavax Technologies Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

15 oct 2025, 23:25 UTC

Principales Movimientos del Mercado

Salesforce Rises on New FY30 Financial Targets

15 oct 2025, 18:52 UTC

Ganancias

Principales Movimientos del Mercado

Prologis Shares Gain on Raised Outlook, Data Center Growth

15 oct 2025, 18:30 UTC

Adquisiciones, fusiones, absorciones

Constellation Software to Buy U.K.'s Tecvia Holding

15 oct 2025, 17:19 UTC

Adquisiciones, fusiones, absorciones

Drahi's Altice Rejects $20 Billion Joint Offer From Peers -- 2nd Update

15 oct 2025, 17:11 UTC

Adquisiciones, fusiones, absorciones

Anglo American, MMG Offer Concessions to EU Merger Watchdog in Nickel Deal Probe

15 oct 2025, 23:48 UTC

Charlas de Mercado

Gold Steady, Supported by Expectations of Ongoing Central Bank Purchases -- Market Talk

15 oct 2025, 23:38 UTC

Charlas de Mercado

Nikkei May Rise, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15 oct 2025, 22:37 UTC

Charlas de Mercado

Economic Stars Are Aligning for RBA -- Market Talk

15 oct 2025, 21:44 UTC

Ganancias

Stock Rally Is Lifting Wealth Managers. How Much Is Charles Schwab Benefiting? -- Barrons.com

15 oct 2025, 20:50 UTC

Charlas de Mercado

Ganancias

Financial Services Roundup: Market Talk

15 oct 2025, 20:44 UTC

Adquisiciones, fusiones, absorciones

Restaurant Brands Recommends Hldrs Do Not Tender Their Shrs to the Offer >QSR.T

15 oct 2025, 20:44 UTC

Adquisiciones, fusiones, absorciones

Restaurant Brands Notified of Unsolicited Mini-Tender Offer to Buy Shrs at $28.80/Shr

15 oct 2025, 20:43 UTC

Adquisiciones, fusiones, absorciones

Restaurant Brands Notified of Unsolicited Mini-Tender Offer by NY Stk and Bond LLC to Purchase Up to 10,000 Common Shrs >QSR.T

15 oct 2025, 20:34 UTC

Ganancias

Prologis Raises Outlook as Warehouse Leasing Picks Up -- WSJ

15 oct 2025, 20:31 UTC

Adquisiciones, fusiones, absorciones

RBI Recommends Hldrs Reject NYSB's "Mini-Tender Offer"

15 oct 2025, 20:17 UTC

Adquisiciones, fusiones, absorciones

GE Vernova Stock Feill With Latest Call to Sell -- Barrons.com

15 oct 2025, 19:06 UTC

Ganancias

These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More -- Barrons.com

15 oct 2025, 19:04 UTC

Charlas de Mercado

Oil Futures Post Back-to-Back Losses -- Market Talk

15 oct 2025, 18:46 UTC

Charlas de Mercado

U.S. Natural Gas Futures Slip Ahead of Storage Data -- Market Talk

15 oct 2025, 18:23 UTC

Ganancias

This Insurer Is the One of the Worst Stocks in the S&P 500 Today. Here's Why. -- Barrons.com

15 oct 2025, 17:37 UTC

Adquisiciones, fusiones, absorciones

Constellation Software's Harris Operating Group Enters Into Agreement To Acquire TECVIA Holding GmbH >CSU.T

15 oct 2025, 17:34 UTC

Charlas de Mercado

Oil Futures Lose Ground on Trade, Oversupply Concerns -- Market Talk

15 oct 2025, 16:57 UTC

Ganancias

The Nation's Biggest Banks Are Saying the Economy Is Still Strong -- WSJ

15 oct 2025, 16:51 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica Doesn't Disclose Financial Details

15 oct 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

15 oct 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

15 oct 2025, 16:48 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

15 oct 2025, 16:48 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

15 oct 2025, 16:47 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica Buys Ikerian

15 oct 2025, 16:34 UTC

Charlas de Mercado

AMD Data Center Agreements Will Provide Big Revenue Growth -- Market Talk

Comparación entre iguales

Cambio de precio

Dynavax Technologies Corp previsión

Precio Objetivo

By TipRanks

130.62% repunte

Estimación a 12 Meses

Media 22.67 USD 130.62%

Máximo 32 USD

Mínimo 11 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Dynavax Technologies Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Dynavax Technologies Corp Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

9.62 / 10.9Soporte y Resistencia

Recent bearish events outweigh bullish events.

All events are bearish.

Sentimiento

By Acuity

94 / 371 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Dynavax Technologies Corp

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.